All while the Africa CDC suspects that this outbreak may prove to eclipse the 12,000 deaths in 2012-14, before it is all over. But here is the encouraging news, just the same:
. . .NAIROBI/DAKAR, June 16 (Reuters) -- Lead vaccine candidates developed by Oxford University and Moderna against Ebola Bundibugyo, the deadly virus that has swept through eastern Democratic Republic of Congo, could enter Phase 1 trials as early as July 1, with field trials possible within several months, the head of the Coalition for Epidemic Preparedness Innovations, Richard Hatchett, said on Tuesday. . . .
Excellent, indeed. Speed onward, you biological science-mavens -- we need your help desperately now in DRC and Uganda.
नमस्ते








No comments:
Post a Comment